PROTAC
Read More about this categoryShow Less
The PROTAC molecule itself contains three distinct portions: a ligand for binding to the target protein, a ligand for binding to an E3 ligase, and a linker joining these two ligands.
PROTACs (proteolysis-targeting chimaeras) are bifunctional molecules that bring a target protein into spatial proximity with an E3 ubiquitin ligase to trigger target ubiquitination and subsequent proteasomal degradation. Effective redirection of ligase poly-ubiquitination activity toward a new substrate protein requires formation of a ligase:PROTAC:target ternary complex, an intermediate species that is crucial to the cellular activity of degrader molecules. A characteristic feature of PROTACs mode of action is their sub-stoichiometric catalytic activity that alleviates the requirement for target engagement and occupancy of traditional inhibitors. New PROTAC molecules designed guided by the crystal structure show exquisite selectivity for inducing cellular depletion of Brd4 over its BET family members Brd2 and Brd3.
Products Related to PROTAC(273)
- GC73996PROTAC AR/AR-V7 degrader-1CAS: 2841308-96-9Purity: >98.00%
PROTAC AR/AR-V7 degrader-1 (27c) is a PROTAC-based and dual AR, AR-V7 degrader, with DC50 values of 2.67 and 2.64 μM for AR and AR-V7, respectively.
- GC74013FOSL1 degrader 1
FOSL1 degrader 1 (4) is a T-5224-PROTAC, potently degrade FOSL1 (AP-1) to suppress cancer stemness gene expression in HNSCC.
- GC74027DAS-5-oCRBNPurity: >98.00%
DAS-5-oCRBN is a selective and potent PROTAC degrader of c-Src kinase.
- GC74050PROTAC CDK4/6 degrader 1CAS: 3025082-14-5Purity: >98.00%
PROTAC CDK4/6 degrader 1 (Compound 7f) is a dual degrader for CDK4 and CDK6 with DC50 of 10.5 and 2.5 nM.
- GC74412xStAx-VHLL TFAPurity: >99.00%
xStAx-VHLL TFA, a PROTAC, sustains β-catenin degradation and manifested strong inhibition of Wnt signaling. xStAx-VHLL TFA promotes β-catenin ubiquitination.
- GC79419PROTAC BCL6 Degrader-2Purity: >99.50%
PROTAC BCL6 Degrader-2 is an orally active, selective BCL6 PROTAC degrader ( DC 50 : 0.45 nM in HEK293T cells).
- GC80853(4R,5S)-YX-02-030CAS: 3049077-01-9Purity: >99.50%
(4R,5S)-YX-02-030 is an isomer of YX-02-030.
- GC80856(R,R)-BexobrutidegCAS: 2649400-33-7Purity: >98.50%
(R,R)-Bexobrutideg is the (R,R)-enantiomer of Bexobrutideg.
- GC80875PROTAC survivin degrader-1CAS: 3079079-69-6Purity: >98%
PROTAC survivin degrader-1 is an orally active, CNS-penetrant survivin -targeting PROTAC.
- GC80877LD-110 triTFAPurity: >99.50%
LD-110 triTFA is a highly efficient and effective LSD1 PROTAC degrader ( DC 50 = 0.44 μM).
- GC80881PROTAC DAPK1 Degrader-1CAS: 3063030-38-3Purity: >96.50%
PROTAC DAPK1 Degrader-1 is a death-associated protein kinase 1 (DAPK1) degrader with a DC 50 of 119.6 nM.
- GC80885PROTAC CDK6 Degrader 1Purity: >98.50%
PROTAC CDK6 Degrader 1 (compound 48a) is a potent and selective PROTAC CDK6 degrader with a DC 50 of 0.037 μM.
- GC80886PROTAC CDK2/4/6 Degrader-2CAS: 2541626-49-5Purity: >97.00%
PROTAC CDK2/4/6 Degrader-2 is a CDK2/4/6 PROTAC degrader.
- GC80888PROTAC PLK1 Degrader-2Purity: >99.00%
PROTAC PLK1 Degrader-2 is a peptide-based N-end rule PLK1 mini-PROTAC.
- GC80889PROTAC HDAC4 Degrader-2CAS: 3035189-46-6Purity: >98%
PROTAC HDAC4 Degrader-2 is a class IIa selective negative control for HDAC4 PROTAC degraders, with an IC 50 of 0.15 μM against HDAC4 and a cellular IC 50 of 0.18 μM.
- GC80893PROTAC CDK2/4 Degrader-1Purity: >98.00%
PROTAC CDK2/4 Degrader-1 is a PROTAC degrader of cyclin-dependent kinase 2 ( CDK2 ) and cyclin-dependent kinase 4 ( CDK4 ).
- GC80894(S)-JWZ-5-13Purity: >99.50%
(S)-JWZ-5-13 (compound 17-Neg), a PROTAC CDK7 degrader, is a negative control compound of JWZ-5-13.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC73996 | PROTAC AR/AR-V7 degrader-1 | 2841308-96-9 | >98.00% | |
PROTAC AR/AR-V7 degrader-1 (27c) is a PROTAC-based and dual AR, AR-V7 degrader, with DC50 values of 2.67 and 2.64 μM for AR and AR-V7, respectively. | ||||
| GC74013 | FOSL1 degrader 1 | - | - | |
FOSL1 degrader 1 (4) is a T-5224-PROTAC, potently degrade FOSL1 (AP-1) to suppress cancer stemness gene expression in HNSCC. | ||||
| GC74027 | DAS-5-oCRBN | - | >98.00% | |
DAS-5-oCRBN is a selective and potent PROTAC degrader of c-Src kinase. | ||||
| GC74035 | AU-24118 | - | >98.00% | |
AU-24118 is orally bioavailable proteolysis targeting chimera (PROTAC) degrader of mSWI/SNF ATPases (SMARCA2 and SMARCA4) and PBRM1. | ||||
| GC74044 | ARM165 | - | >99.00% | |
ARM165 is a heterobifunctional molecule. | ||||
| GC74050 | PROTAC CDK4/6 degrader 1 | 3025082-14-5 | >98.00% | |
PROTAC CDK4/6 degrader 1 (Compound 7f) is a dual degrader for CDK4 and CDK6 with DC50 of 10.5 and 2.5 nM. | ||||
| GC74412 | xStAx-VHLL TFA | - | >99.00% | |
xStAx-VHLL TFA, a PROTAC, sustains β-catenin degradation and manifested strong inhibition of Wnt signaling. xStAx-VHLL TFA promotes β-catenin ubiquitination. | ||||
| GC79180 | YZ-836P | 3086041-35-9 | >98.00% | |
YZ-836P is a Protein arginine methyltransferase 5 ( PRMT5 ) targeting agent. | ||||
| GC79419 | PROTAC BCL6 Degrader-2 | - | >99.50% | |
PROTAC BCL6 Degrader-2 is an orally active, selective BCL6 PROTAC degrader ( DC 50 : 0.45 nM in HEK293T cells). | ||||
| GC80853 | (4R,5S)-YX-02-030 | 3049077-01-9 | >99.50% | |
(4R,5S)-YX-02-030 is an isomer of YX-02-030. | ||||
| GC80856 | (R,R)-Bexobrutideg | 2649400-33-7 | >98.50% | |
(R,R)-Bexobrutideg is the (R,R)-enantiomer of Bexobrutideg. | ||||
| GC80875 | PROTAC survivin degrader-1 | 3079079-69-6 | >98% | |
PROTAC survivin degrader-1 is an orally active, CNS-penetrant survivin -targeting PROTAC. | ||||
| GC80876 | G9D-4 TFA | - | >99.00% | |
G9D-4 TFA is a G9a PROTAC degrader. | ||||
| GC80877 | LD-110 triTFA | - | >99.50% | |
LD-110 triTFA is a highly efficient and effective LSD1 PROTAC degrader ( DC 50 = 0.44 μM). | ||||
| GC80880 | dCASP1-55 | - | >98% | |
dCASP1-55 is a cereblon-dependent caspase-1 ( CASP1 ) PROTAC degrader. | ||||
| GC80881 | PROTAC DAPK1 Degrader-1 | 3063030-38-3 | >96.50% | |
PROTAC DAPK1 Degrader-1 is a death-associated protein kinase 1 (DAPK1) degrader with a DC 50 of 119.6 nM. | ||||
| GC80884 | CXJ2080 | - | >98% | |
CXJ2080 is a selective PROTAC-based CDK7 degrader with a DC 50 of 0.88 nM. | ||||
| GC80885 | PROTAC CDK6 Degrader 1 | - | >98.50% | |
PROTAC CDK6 Degrader 1 (compound 48a) is a potent and selective PROTAC CDK6 degrader with a DC 50 of 0.037 μM. | ||||
| GC80886 | PROTAC CDK2/4/6 Degrader-2 | 2541626-49-5 | >97.00% | |
PROTAC CDK2/4/6 Degrader-2 is a CDK2/4/6 PROTAC degrader. | ||||
| GC80887 | MA203 | - | >98% | |
MA203 is a selective CHK1 PROTAC degrader. | ||||
| GC80888 | PROTAC PLK1 Degrader-2 | - | >99.00% | |
PROTAC PLK1 Degrader-2 is a peptide-based N-end rule PLK1 mini-PROTAC. | ||||
| GC80889 | PROTAC HDAC4 Degrader-2 | 3035189-46-6 | >98% | |
PROTAC HDAC4 Degrader-2 is a class IIa selective negative control for HDAC4 PROTAC degraders, with an IC 50 of 0.15 μM against HDAC4 and a cellular IC 50 of 0.18 μM. | ||||
| GC80893 | PROTAC CDK2/4 Degrader-1 | - | >98.00% | |
PROTAC CDK2/4 Degrader-1 is a PROTAC degrader of cyclin-dependent kinase 2 ( CDK2 ) and cyclin-dependent kinase 4 ( CDK4 ). | ||||
| GC80894 | (S)-JWZ-5-13 | - | >99.50% | |
(S)-JWZ-5-13 (compound 17-Neg), a PROTAC CDK7 degrader, is a negative control compound of JWZ-5-13. | ||||
